Articles with public access mandates - Andrey LobodaLearn more
Available somewhere: 23
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
R Cristescu, R Mogg, M Ayers, A Albright, E Murphy, J Yearley, X Sher, ...
Science 362 (6411), eaar3593, 2018
Mandates: US National Institutes of Health
Cancer-associated fibroblasts neutralize the anti-tumor effect of CSF1 receptor blockade by inducing PMN-MDSC infiltration of tumors
V Kumar, L Donthireddy, D Marvel, T Condamine, F Wang, ...
Cancer cell 32 (5), 654-668. e5, 2017
Mandates: US National Institutes of Health
Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study
E Galanis, KA Jaeckle, MJ Maurer, JM Reid, MM Ames, JS Hardwick, ...
Journal of clinical oncology 27 (12), 2052-2058, 2009
Mandates: US National Institutes of Health
Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling
D Coppola, M Nebozhyn, F Khalil, H Dai, T Yeatman, A Loboda, JJ Mulé
The American journal of pathology 179 (1), 37-45, 2011
Mandates: US National Institutes of Health
EMT is the dominant program in human colon cancer
A Loboda, MV Nebozhyn, JW Watters, CA Buser, PM Shaw, PS Huang, ...
BMC medical genomics 4, 1-10, 2011
Mandates: US National Institutes of Health
Functional genomics identifies therapeutic targets for MYC-driven cancer
M Toyoshima, HL Howie, M Imakura, RM Walsh, JE Annis, AN Chang, ...
Proceedings of the National Academy of Sciences 109 (24), 9545-9550, 2012
Mandates: US National Institutes of Health
Transcriptional architecture of the primate neocortex
A Bernard, LS Lubbers, KQ Tanis, R Luo, AA Podtelezhnikov, EM Finney, ...
Neuron 73 (6), 1083-1099, 2012
Mandates: US National Institutes of Health
A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC
MJ Schell, M Yang, JK Teer, FY Lo, A Madan, D Coppola, ANA Monteiro, ...
Nature communications 7 (1), 11743, 2016
Mandates: US National Institutes of Health
Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination
S Fourati, R Cristescu, A Loboda, A Talla, A Filali, R Railkar, AK Schaeffer, ...
Nature communications 7 (1), 10369, 2016
Mandates: US National Institutes of Health
Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice
F Veglia, A Hashimoto, H Dweep, E Sanseviero, A De Leo, E Tcyganov, ...
Journal of Experimental Medicine 218 (4), 2021
Mandates: US National Institutes of Health
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02
E Galanis, SK Anderson, CR Miller, JN Sarkaria, K Jaeckle, JC Buckner, ...
Neuro-oncology 20 (4), 546-556, 2018
Mandates: US National Institutes of Health, Damon Runyon Cancer Research Foundation
Molecular insights into the pathogenesis of Alzheimer's disease and its relationship to normal aging
AA Podtelezhnikov, KQ Tanis, M Nebozhyn, WJ Ray, DJ Stone, ...
PloS one 6 (12), e29610, 2011
Mandates: US National Institutes of Health
A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer
F Sclafani, TY Kim, D Cunningham, TW Kim, J Tabernero, HJ Schmoll, ...
Journal of the National Cancer Institute 107 (12), djv258, 2015
Mandates: National Institute for Health Research, UK
Network-driven plasma proteomics expose molecular changes in the Alzheimer’s brain
PA Jaeger, KM Lucin, M Britschgi, B Vardarajan, RP Huang, ED Kirby, ...
Molecular neurodegeneration 11, 1-18, 2016
Mandates: US National Institutes of Health, US Department of Veterans Affairs
A composite gene expression signature optimizes prediction of colorectal cancer metastasis and outcome
MJ Schell, M Yang, E Missiaglia, M Delorenzi, C Soneson, B Yue, ...
Clinical Cancer Research 22 (3), 734-745, 2016
Mandates: US National Institutes of Health
Associations of tissue tumor mutational burden and mutational status with clinical outcomes with pembrolizumab plus chemotherapy versus chemotherapy for metastatic NSCLC
MC Garassino, S Gadgeel, S Novello, B Halmos, E Felip, G Speranza, ...
JTO Clinical and Research Reports 4 (1), 100431, 2023
Mandates: US National Institutes of Health
Predicting response to histone deacetylase inhibitors using high-throughput genomics
P Geeleher, A Loboda, D Lenkala, F Wang, B LaCroix, S Karovic, J Wang, ...
Journal of the National Cancer Institute 107 (11), djv247, 2015
Mandates: US National Institutes of Health
Repurposing EGFR Inhibitor Utility in Colorectal Cancer in Mutant APC and TP53 Subpopulations
M Yang, MJ Schell, A Loboda, M Nebozhyn, J Li, JK Teer, WJ Pledger, ...
Cancer Epidemiology, Biomarkers & Prevention 28 (7), 1141-1152, 2019
Mandates: US National Institutes of Health
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016
A Lundqvist, V van Hoef, X Zhang, E Wennerberg, J Lorent, K Witt, ...
Journal for immunotherapy of cancer 4, 1-106, 2016
Mandates: US National Institutes of Health
An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy
M Yang, TB Davis, L Pflieger, MV Nebozhyn, A Loboda, H Wang, ...
BMC cancer 22 (1), 256, 2022
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program